EUVIMEDEUVIMED entdecken
Open Access

PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer

Rui Li, Jie He, Chaoqun Liu, Zesheng Jiang, Jiasheng Qin, Kun Liang, Zhuocheng Ji, Liang Zhao

Theranostics · 2025

DOI: 10.7150/thno.100793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Rui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Immune Checkpoint Inhibitors, DNA-Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our study established that PBRM1/Pbrm1 deficiency was positively correlated with PD1 immunotherapeutic sensitivity in colorectal cancer. The underlying molecular mechanisms involved regulation of chromosome accessibility, activation of the NF-κB signaling pathway, and immune cell infiltration in the microenvironment. These findings identify potential molecular targets for enhancing immunotherapy for colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmImmune Checkpoint InhibitorsDNA-Binding ProteinsTranscription FactorsExome SequencingMutationTumor MicroenvironmentMice, Inbred BALB CLymphocytes, Tumor-InfiltratingProgrammed Cell Death 1 ReceptorCell LineOrganoidsHumansFemaleAnimalsMiceMice, NudeMice, KnockoutXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticKaplan-Meier EstimateSurvival RateNF-kappa BSignal Transduction

Stichwörter der Autor:innen

Chromosome accessibilityColorectal cancerExosomePBRM1PD1 immunotherapeutic

Substanzen

PBRM1 protein, humanProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsPbrm1 protein, mouseDNA-Binding ProteinsTranscription FactorsNF-kappa B

Autor:innen und Institutionen

  • Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China.
  • Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, Basic Medical College, Southern Medical University, Guangzhou, China.
  • Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Live…

Zitieren

APA

Li, R., He, J., Liu, C., Jiang, Z., Qin, J., Liang, K., Ji, Z., & Zhao, L. (2025). PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer. Theranostics. https://doi.org/10.7150/thno.100793

Vancouver

Li R, He J, Liu C, Jiang Z, Qin J, Liang K, et al. PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer. Theranostics. 2025. doi:10.7150/thno.100793

BibTeX
@article{Li2025,
  author = {Li, Rui and He, Jie and Liu, Chaoqun and Jiang, Zesheng and Qin, Jiasheng and Liang, Kun and Ji, Zhuocheng and Zhao, Liang},
  title = {PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.100793}
}
Kostenlos starten →